Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,133	1,071	674	103	439	605
Market Cap Growth	125.03%	58.86%	553.77%	-76.50%	-27.42%	116.90%
Enterprise Value	1,022	1,000	633	109	409	587
Last Close Price	16.84	17.41	12.24	2.77	14.81	23.86
PS Ratio	-	-	-	147.32	309.48	-
PB Ratio	9.56	9.32	15.20	-45.87	12.30	26.41
P/TBV Ratio	9.89	9.66	16.99	-	14.78	37.28
EV/Sales Ratio	-	-	-	156.14	288.38	-
Debt / Equity Ratio	0.07	0.08	0.21	-33.79	0.32	0.50
Asset Turnover	-	-	-	0.01	0.03	-
Quick Ratio	15.37	11.74	6.61	10.22	3.37	2.70
Current Ratio	15.58	11.88	6.76	10.39	4.30	2.95
Return on Equity (ROE)	-77.86%	-67.31%	-200.46%	-349.89%	-217.33%	-185.90%
Return on Assets (ROA)	-43.61%	-36.70%	-39.75%	-54.93%	-82.44%	-75.06%
Return on Capital (ROIC)	-46.23%	-39.67%	-42.82%	-60.15%	-97.02%	-87.10%
Earnings Yield	-5.32%	-5.00%	-6.26%	-56.73%	-14.51%	-8.24%
FCF Yield	-3.55%	-3.40%	-4.92%	-45.98%	-12.43%	-5.92%
Buyback Yield / Dilution	-11.39%	-17.41%	-46.56%	-21.35%	-20.29%	-12.06%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q